Maksim Aleksandrovich Kutin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maksim Aleksandrovich Kutin has a total of 196 co-authors. Here are the top co-authors by number of shared publications:
- Pavel Lvovich Kalinin
N.N. Burdenko National Medical Research Center of Neurosurgery, Ministry of Health of Russia
39 shared publications - Dmitrii V. Fomichev
N.N. Burdenko National Medical Research Center of Neurosurgery, Ministry of Health of Russia
27 shared publications - Oleg I. Sharipov
N.N. Burdenko National Medical Research Center of Neurosurgery, Ministry of Health of Russia
25 shared publications - Ilia Valerievich Chernov
N.N. Burdenko National Medical Research Center of Neurosurgery, Ministry of Health of Russia
18 shared publications - Ludmila Astafyeva
N. N. Burdenko National Medical Research Center of Neurosurgery, Ministry of Health of Russia
16 shared publications - Aleksey Nikolaevich Shkarubo
N.N. Burdenko National Medical Research Center of Neurosurgery, Ministry of Health of Russia
15 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by "MedINK" Publishing House in Russian journal of neurosurgery
- Vol. 28 (3) , 67-77
Single-catheter biventricular drainage in patients with chiasmatic–sellar region tumors
Background. Tumors of the chiasmatic-sellar region (CSR) – pituitary adenomas, craniopharyngiomas, meningiomas, gliomas, and other neoplasms – account for about 15 % of all primary brain tumors. Extension into the third ventricle can cause obstructive hydrocephalus with isolation of the lateral ventricles, requiring simultaneous drainage of both lateral ventricles. Conventional biventricular shunting techniques (drainage of the anterior or posterior horns with two catheters) are technically demanding, more traumatic, and increase the number of shunt system components. Aim. To evaluate the efficacy and safety of biventricular drainage using a single ventricular catheter in patients with CSR tumors. Materials and methods. The study included 12 patients (5 men, 7 women; mean age 58 years) with CSR tumors (pituitary adenoma, n = 6; low-grade glioma, n = 3; craniopharyngioma, n = 2; spindle cell oncocytoma, n = 1) and occlusive hydrocephalus at the level of both foramina of Monro. In 8 cases, a single catheter was placed via a transventricular transseptal approach into both lateral ventricles; in 4 cases, catheter placement was performed under endoscopic control through a posterior-horn septostomy. Results. All patients showed improvement in neurological status. No early or late postoperative complications or shunt-associated infections occurred in 11 of 12 patients, and shunt systems were correctly positioned in all cases. One patient developed dysfunction of the contralateral shunt segment 6 months after surgery, requiring reoperation. Mean hospital stay was 27 days (median 8.5 days). Conclusion. Draining both lateral ventricles with a single ventricular catheter – via a transventricular-transseptal route or under endoscopic septostomy control – is technically feasible and safe, has a standard complication rate, allows the use of a conventional shunt system, and preserves unobstructed surgical access for subsequent transcranial tumor removal.
- 19 October 2026
- Published by "MedINK" Publishing House in Russian journal of neurosurgery
- Vol. 28 (3) , 67-77
Open AccessSingle-catheter biventricular drainage in patients with chiasmatic–sellar region tumors
Background. Tumors of the chiasmatic-sellar region (CSR) – pituitary adenomas, craniopharyngiomas, meningiomas, gliomas, and other neoplasms – account for about 15 % of all primary brain tumors. Extension into the third ventricle can cause obstructive hydrocephalus with isolation of the lateral ventricles, requiring simultaneous drainage of both lateral ventricles. Conventional biventricular shunting techniques (drainage of the anterior or posterior horns with two catheters) are technically demanding, more traumatic, and increase the number of shunt system components. Aim. To evaluate the efficacy and safety of biventricular drainage using a single ventricular catheter in patients with CSR tumors. Materials and methods. The study included 12 patients (5 men, 7 women; mean age 58 years) with CSR tumors (pituitary adenoma, n = 6; low-grade glioma, n = 3; craniopharyngioma, n = 2; spindle cell oncocytoma, n = 1) and occlusive hydrocephalus at the level of both foramina of Monro. In 8 cases, a single catheter was placed via a transventricular transseptal approach into both lateral ventricles; in 4 cases, catheter placement was performed under endoscopic control through a posterior-horn septostomy. Results. All patients showed improvement in neurological status. No early or late postoperative complications or shunt-associated infections occurred in 11 of 12 patients, and shunt systems were correctly positioned in all cases. One patient developed dysfunction of the contralateral shunt segment 6 months after surgery, requiring reoperation. Mean hospital stay was 27 days (median 8.5 days). Conclusion. Draining both lateral ventricles with a single ventricular catheter – via a transventricular-transseptal route or under endoscopic septostomy control – is technically feasible and safe, has a standard complication rate, allows the use of a conventional shunt system, and preserves unobstructed surgical access for subsequent transcranial tumor removal.
- Open Access
- 19 October 2026
- Published by "MedINK" Publishing House in Russian journal of neurosurgery
- Vol. 28 (3) , 22‑32
Endoscopic endonasal surgery in the treatment of skull base plasmacytomas
Background. Solitary plasmacytoma (plasma cell tumor) is a rare immunoproliferative monoclonal tumor composed of B cells. There are two main forms, such as bone plasmacytoma and extramedullary soft tissue plasmacytoma. Aim. To analyze the overall and progression-free survival of patients with skull base plasmacytomas after combined treatment (surgery and chemoradiation) as well as to conduct a comparative analysis of recurrence-free survival times depending on the extent of tumor resection. Materials and methods. From 2010 to 2021, 40 patients with skull base plasmacytomas were operated on at Burdenko National Medical Research Center of Neurosurgery using a transnasal endoscopic approach. Results and conclusion. Subtotal resection of plasmacytoma were achieved in 24 (62 %) patients; biopsies were performed in 16 (38 %) patients. Tumor biopsy combined with chemoradiotherapy yields similarly effective progression-free survival results as more radical tumor resection (p <0.05). No statistically significant difference was found between the two curves (Cox F-test p = 0.07). The radicality of tumor resection does not affect the survival of patients with skull base plasmacytomas.
- 19 October 2026
- Published by "MedINK" Publishing House in Russian journal of neurosurgery
- Vol. 28 (3) , 22‑32
Open AccessEndoscopic endonasal surgery in the treatment of skull base plasmacytomas
Background. Solitary plasmacytoma (plasma cell tumor) is a rare immunoproliferative monoclonal tumor composed of B cells. There are two main forms, such as bone plasmacytoma and extramedullary soft tissue plasmacytoma. Aim. To analyze the overall and progression-free survival of patients with skull base plasmacytomas after combined treatment (surgery and chemoradiation) as well as to conduct a comparative analysis of recurrence-free survival times depending on the extent of tumor resection. Materials and methods. From 2010 to 2021, 40 patients with skull base plasmacytomas were operated on at Burdenko National Medical Research Center of Neurosurgery using a transnasal endoscopic approach. Results and conclusion. Subtotal resection of plasmacytoma were achieved in 24 (62 %) patients; biopsies were performed in 16 (38 %) patients. Tumor biopsy combined with chemoradiotherapy yields similarly effective progression-free survival results as more radical tumor resection (p <0.05). No statistically significant difference was found between the two curves (Cox F-test p = 0.07). The radicality of tumor resection does not affect the survival of patients with skull base plasmacytomas.
- Open Access
- 5 August 2026
- Published by Endocrinology Research Centre in Endocrine Surgery
- Vol. 20 (1) , 8-29
Multidisciplinary Consensus on the Neurosurgical Management of Patients with Pituitary Adenomas (Endorsed by the Russian Association of Endocrinologists and the Association of Neurosurgeons of Russia)
This consensus outlines the key information regarding the course of the disease and treatment approaches for patients with pituitary adenomas. A multidisciplinary team of specialists, including a neurosurgeon, an endocrinologist, and a radiotherapist, carries out the management of this patient group. The document details the current understanding of the course of the disease and treatment methods for somatotroph, corticotroph, prolactin-secreting, thyrotroph, and clinically non-functioning pituitary adenomas. The applied treatment modalities include surgical, medical, and radiotherapeutic approaches. The choice of strategy depends on hormonal activity, tumor size, direction of growth, the severity of mass effect, and the presence of somatoneurological complications. Patients should be followed by specialists with the appropriate expertise to diagnose and manage the full spectrum of pituitary adenomas. Upon diagnosis of a pituitary adenoma, consultation with a neurosurgeon, radiologist, and radiotherapist is recommended to exclude meningiomas, craniopharyngiomas, and other neoplasms of the sellar region. For all patients with acromegaly who are candidates for neurosurgical treatment, surgery is recommended to be performed at medical centers specializing in pituitary disorders. In the vast majority of cases, medical therapy for acromegaly is recommended as second-line therapy. Radiotherapy constitutes the third line of treatment for acromegaly. The treatment of Cushing’s disease involves surgical, medical, and radiotherapeutic interventions. First-line treatment consists of endoscopic transnasal adenomectomy performed at an expert-level center. In cases where surgery is ineffective, repeat surgery may be considered. Medical therapy or radiotherapy are used as second-line options. In life-threatening hypercortisolism, bilateral adrenalectomy is performed. The management of prolactin-secreting adenomas involves three main methods: medical, surgical, and radiotherapeutic. Medical therapy is the preferred treatment modality. Surgery is not the treatment of choice for prolactinomas. Adenomectomy is recommended for patients with intolerance or resistance to conservative therapy, or when absolute indications are present. Upon confirmation of a thyrotropinoma diagnosis, endoscopic transnasal adenomectomy is performed in a specialized medical facility. If surgery is not feasible or for preoperative preparation, somatostatin analogs are used. Thyrostatic agents are not indicated. For clinically non-functioning pituitary adenomas, surgical treatment is indicated in the presence of: visual field deficits and decreased visual acuity caused by compression of the optic chiasm and optic tracts; oculomotor disturbances such as ophthalmoplegia, diplopia, or other neurological disorders resulting from pathological compression of adjacent neural structures; pituitary apoplexy with visual disturbances; impaired cerebrospinal fluid outflow, hydrocephalus, and intracranial hypertension caused by tumor extension into the third ventricle; CSF rhinorrhea resulting from tumor-induced destruction of the diaphragm and the floor of the sella turcica.
- 5 August 2026
- Published by Endocrinology Research Centre in Endocrine Surgery
- Vol. 20 (1) , 8-29
Open AccessMultidisciplinary Consensus on the Neurosurgical Management of Patients with Pituitary Adenomas (Endorsed by the Russian Association of Endocrinologists and the Association of Neurosurgeons of Russia)
This consensus outlines the key information regarding the course of the disease and treatment approaches for patients with pituitary adenomas. A multidisciplinary team of specialists, including a neurosurgeon, an endocrinologist, and a radiotherapist, carries out the management of this patient group. The document details the current understanding of the course of the disease and treatment methods for somatotroph, corticotroph, prolactin-secreting, thyrotroph, and clinically non-functioning pituitary adenomas. The applied treatment modalities include surgical, medical, and radiotherapeutic approaches. The choice of strategy depends on hormonal activity, tumor size, direction of growth, the severity of mass effect, and the presence of somatoneurological complications. Patients should be followed by specialists with the appropriate expertise to diagnose and manage the full spectrum of pituitary adenomas. Upon diagnosis of a pituitary adenoma, consultation with a neurosurgeon, radiologist, and radiotherapist is recommended to exclude meningiomas, craniopharyngiomas, and other neoplasms of the sellar region. For all patients with acromegaly who are candidates for neurosurgical treatment, surgery is recommended to be performed at medical centers specializing in pituitary disorders. In the vast majority of cases, medical therapy for acromegaly is recommended as second-line therapy. Radiotherapy constitutes the third line of treatment for acromegaly. The treatment of Cushing’s disease involves surgical, medical, and radiotherapeutic interventions. First-line treatment consists of endoscopic transnasal adenomectomy performed at an expert-level center. In cases where surgery is ineffective, repeat surgery may be considered. Medical therapy or radiotherapy are used as second-line options. In life-threatening hypercortisolism, bilateral adrenalectomy is performed. The management of prolactin-secreting adenomas involves three main methods: medical, surgical, and radiotherapeutic. Medical therapy is the preferred treatment modality. Surgery is not the treatment of choice for prolactinomas. Adenomectomy is recommended for patients with intolerance or resistance to conservative therapy, or when absolute indications are present. Upon confirmation of a thyrotropinoma diagnosis, endoscopic transnasal adenomectomy is performed in a specialized medical facility. If surgery is not feasible or for preoperative preparation, somatostatin analogs are used. Thyrostatic agents are not indicated. For clinically non-functioning pituitary adenomas, surgical treatment is indicated in the presence of: visual field deficits and decreased visual acuity caused by compression of the optic chiasm and optic tracts; oculomotor disturbances such as ophthalmoplegia, diplopia, or other neurological disorders resulting from pathological compression of adjacent neural structures; pituitary apoplexy with visual disturbances; impaired cerebrospinal fluid outflow, hydrocephalus, and intracranial hypertension caused by tumor extension into the third ventricle; CSF rhinorrhea resulting from tumor-induced destruction of the diaphragm and the floor of the sella turcica.
- 30 June 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 7,p. 1022-1029
Early complications after pedicled nasoseptal flap reconstruction of central skull base defects
Endoscopic reconstruction of central skull base defects is performed after surgery for tumors of the chiasmatic — sellar and parasellar regions, as well as for nasal cerebrospinal fluid leaks of various origins. Surgeons are increasingly performing extensive interventions through wide incisions, requiring more complex plastic closure of the defects. In 2006, G. Haddad et al. proposed using a pedicled naso — septal flap as a plastic material, which reduced the incidence of postoperative nasal cerebrospinal fluid leaks from 20 % to 5 %. Currently, the use of the naso — septal flap is widespread enough that it has become possible to analyze complications after its use at the current level. The purpose of this article is to present complications after the use of the naso — septal flap that arise in the early postoperative period. Material and methods. A single — center prospective study was conducted at the Burdenko National Medical Research Center of Neurosurgery from 2024 to 2025. The study included 45 patients, 32 patients (71.11 %) with neoplasms of the chiasmatic — sellar and suprasellar localization, 10 patients (22.22 %) with spontaneous nasal cerebrospinal fluid leakage, and 3 patients (6.67 %) with secondary nasal cerebrospinal fluid leakage. Results. In the early postoperative period, olfactory impairment was detected in 24 cases (53.33 %), nosebleeds in 4 cases (8.89 %), nasal cerebrospinal fluid leakage in 2 patients (4.44 %), and flap necrosis in 1 patient (2.22 %). Conclusions. Despite the high efficacy of the naso — septal flap as a plastic material, its use is associated with the risk of specific complications. These results indicate the need for further study of complications and their predictors in both the early and late postoperative periods to optimize surgical tactics.
- 30 June 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 7,p. 1022-1029
Early complications after pedicled nasoseptal flap reconstruction of central skull base defects
Endoscopic reconstruction of central skull base defects is performed after surgery for tumors of the chiasmatic — sellar and parasellar regions, as well as for nasal cerebrospinal fluid leaks of various origins. Surgeons are increasingly performing extensive interventions through wide incisions, requiring more complex plastic closure of the defects. In 2006, G. Haddad et al. proposed using a pedicled naso — septal flap as a plastic material, which reduced the incidence of postoperative nasal cerebrospinal fluid leaks from 20 % to 5 %. Currently, the use of the naso — septal flap is widespread enough that it has become possible to analyze complications after its use at the current level. The purpose of this article is to present complications after the use of the naso — septal flap that arise in the early postoperative period. Material and methods. A single — center prospective study was conducted at the Burdenko National Medical Research Center of Neurosurgery from 2024 to 2025. The study included 45 patients, 32 patients (71.11 %) with neoplasms of the chiasmatic — sellar and suprasellar localization, 10 patients (22.22 %) with spontaneous nasal cerebrospinal fluid leakage, and 3 patients (6.67 %) with secondary nasal cerebrospinal fluid leakage. Results. In the early postoperative period, olfactory impairment was detected in 24 cases (53.33 %), nosebleeds in 4 cases (8.89 %), nasal cerebrospinal fluid leakage in 2 patients (4.44 %), and flap necrosis in 1 patient (2.22 %). Conclusions. Despite the high efficacy of the naso — septal flap as a plastic material, its use is associated with the risk of specific complications. These results indicate the need for further study of complications and their predictors in both the early and late postoperative periods to optimize surgical tactics.
- Open Access
- 19 June 2026
- Published by "MedINK" Publishing House in Russian journal of neurosurgery
- Vol. 28 (2) , 49-56
Meningitis after transsphenoidal pituitary adenoma surgery
Менингиты в транссфеноидальной хирургии аденом гипофиза
- 19 June 2026
- Published by "MedINK" Publishing House in Russian journal of neurosurgery
- Vol. 28 (2) , 49-56
Open AccessMeningitis after transsphenoidal pituitary adenoma surgery
Менингиты в транссфеноидальной хирургии аденом гипофиза
- 25 May 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (3) , 107-114
Odontoidectomy: a systematic review
There is extensive experience of odontoidectomies for various lesions of craniovertebral junction worldwide. Various approaches including those through natural anatomical openings (transoral and transnasal), as well as transcervical one is used. Objective. To compare the outcomes of odontoidectomies through various approaches according to literature data. Material and methods. A systematic review was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. We reviewed the PubMed, Medline and Google Scholar databases using the keyword «odontoidectomy». Results. Analysis included 128 studies describing treatment outcomes in 688 patients. Transoral approach was used in 446 patients, transnasal — in 192, transcervical approach — in 50 patients. Conclusion. Surgical approach for odontoidectomy significantly impacts surgery time, complication rates, initiation of oral feeding and length of hospital-stay.
- 25 May 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (3) , 107-114
Odontoidectomy: a systematic review
There is extensive experience of odontoidectomies for various lesions of craniovertebral junction worldwide. Various approaches including those through natural anatomical openings (transoral and transnasal), as well as transcervical one is used. Objective. To compare the outcomes of odontoidectomies through various approaches according to literature data. Material and methods. A systematic review was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. We reviewed the PubMed, Medline and Google Scholar databases using the keyword «odontoidectomy». Results. Analysis included 128 studies describing treatment outcomes in 688 patients. Transoral approach was used in 446 patients, transnasal — in 192, transcervical approach — in 50 patients. Conclusion. Surgical approach for odontoidectomy significantly impacts surgery time, complication rates, initiation of oral feeding and length of hospital-stay.
- 25 May 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (3) , 73-79
Asymmetric sliding knots for microsutures for skull base defect repair after transnasal endoscopic surgery
The advantage of asymmetrical sliding knot is that it is tightened by pulling only one «main» end of suture, while the other «wrapped» end is inserted into the wound. This method eliminates the need for additional instruments or devices to insert the knot into a narrow and deep wound. Objective. To evaluate feasibility of asymmetrical sliding knots for microsutures in transnasal endoscopic skull base repair. Material and methods. Asymmetric sliding suture was used to attach free autofascial flap to dura mater edges in 25 cases of transnasal endoscopic surgeries with intraoperative cerebrospinal fluid leakage. Craniopharyngiomas were resected in 19 cases, pituitary adenoma in 1 case, meningocele in 1 case, sinonasal carcinomas in 2 cases, chondrosarcoma in 1 case and chordoma in 1 case. Results. Postoperative cerebrospinal fluid leakage was not observed in any case. Conclusion. We confirmed feasibility of asymmetric sliding knots to form microsutures in transnasal endoscopic skull base repair. The key technical parameters of necessary sutures, specifics of needle insertion through the dura mater and free autofascial flap, limitations and difficulties encountered by the authors are described. Sliding interrupted microsutures can be recommended to form dense layer of autologous tissues in transnasal endoscopic skull base repair.
- 25 May 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (3) , 73-79
Asymmetric sliding knots for microsutures for skull base defect repair after transnasal endoscopic surgery
The advantage of asymmetrical sliding knot is that it is tightened by pulling only one «main» end of suture, while the other «wrapped» end is inserted into the wound. This method eliminates the need for additional instruments or devices to insert the knot into a narrow and deep wound. Objective. To evaluate feasibility of asymmetrical sliding knots for microsutures in transnasal endoscopic skull base repair. Material and methods. Asymmetric sliding suture was used to attach free autofascial flap to dura mater edges in 25 cases of transnasal endoscopic surgeries with intraoperative cerebrospinal fluid leakage. Craniopharyngiomas were resected in 19 cases, pituitary adenoma in 1 case, meningocele in 1 case, sinonasal carcinomas in 2 cases, chondrosarcoma in 1 case and chordoma in 1 case. Results. Postoperative cerebrospinal fluid leakage was not observed in any case. Conclusion. We confirmed feasibility of asymmetric sliding knots to form microsutures in transnasal endoscopic skull base repair. The key technical parameters of necessary sutures, specifics of needle insertion through the dura mater and free autofascial flap, limitations and difficulties encountered by the authors are described. Sliding interrupted microsutures can be recommended to form dense layer of autologous tissues in transnasal endoscopic skull base repair.
- 25 May 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (3) , 86-93
Multidisciplinary approach to the treatment of aggressive hormone releasing adenoma: a case report and literature review
Background. Despite available modern therapeutic options for acromegaly, resistant and aggressive forms of growth hormone releasing adenoma remain a significant clinical challenge with unsatisfactory outcomes. Material and methods. The authors present a young patient with invasive growth hormone releasing adenoma characterized by aggressive growth, high proliferation index and previously unreported TP53 gene mutation, PD-L1 and VEGF expression, resistance to somatostatin analogues and no disease control despite combined therapy including growth hormone receptor antagonist. Results. A patient with aggressive somatotropinoma experienced tumor growth despite previous neurosurgical interventions, radio- and chemotherapy, as well as targeted therapy. External beam radiation therapy is recommended as the only treatment option. The authors also examine aspects of multidisciplinary approach, results of antiangiogenic, chemo- and immunotherapy with immune checkpoint inhibitors when neurosurgery, traditional medications, and radiotherapy are ineffective. Conclusion. This case underscores the necessity of extended immunohistochemical profiling and molecular genetic sequencing of pituitary tumors to facilitate development of personalized therapeutic strategies for aggressive somatotropinomas refractory to standard treatment modalities.
- 25 May 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (3) , 86-93
Multidisciplinary approach to the treatment of aggressive hormone releasing adenoma: a case report and literature review
Background. Despite available modern therapeutic options for acromegaly, resistant and aggressive forms of growth hormone releasing adenoma remain a significant clinical challenge with unsatisfactory outcomes. Material and methods. The authors present a young patient with invasive growth hormone releasing adenoma characterized by aggressive growth, high proliferation index and previously unreported TP53 gene mutation, PD-L1 and VEGF expression, resistance to somatostatin analogues and no disease control despite combined therapy including growth hormone receptor antagonist. Results. A patient with aggressive somatotropinoma experienced tumor growth despite previous neurosurgical interventions, radio- and chemotherapy, as well as targeted therapy. External beam radiation therapy is recommended as the only treatment option. The authors also examine aspects of multidisciplinary approach, results of antiangiogenic, chemo- and immunotherapy with immune checkpoint inhibitors when neurosurgery, traditional medications, and radiotherapy are ineffective. Conclusion. This case underscores the necessity of extended immunohistochemical profiling and molecular genetic sequencing of pituitary tumors to facilitate development of personalized therapeutic strategies for aggressive somatotropinomas refractory to standard treatment modalities.
- 14 April 2026
- Published by "MedINK" Publishing House in Russian journal of neurosurgery
- Vol. 28 (1)
Pituitary apoplexy – an urgent operation or a wait-and-see strategy?
Background. Pituitary tumors are a common pathology in neuro-oncology. They constitute 10 % of all intracranial tumors; and for a long time, they may not have any clinical manifestations. In situations where pituitary apoplexy is the first manifestation of the disease, the choice of optimal tactics is particularly relevant. Considering cases of spontaneous tumor resorption after pituitary apoplexy, the standard approach to this pathology as an exceptional urgent one requires revision. Aim. To review the treatment strategy of patients with pituitary apoplexy, identifying factors contributing to both tumor resorption and achievement of a better clinical result. After specification of the indications for surgery, to create an algorithm for treating patients with pituitary apoplexy. Materials and methods. The paper analyzes the results of treatment of 82 patients with pituitary apoplexy. Only 45 patients were operated on. In 37 patients, the need for surgery ceased during preparation. Results. Analysis of treatment results of 82 patients with pituitary apoplexy identified optimal tumor parameters and radiological characteristics for which the probability of spontaneous resorption is the highest: 89.2 % (33 out of 37) cases. The use of dexamethasone as part of therapy has shown to play a key role in achieving optimal results. The analysis of the data allowed us to formulate criteria for which a wait-and-see tactic in pituitary apoplexy can provide a result comparable to the surgical method of treatment and even surpassing it in terms of preservation of pituitary functions. Conclusion. As a result of the study, an algorithm for treatment of patients with pituitary apoplexy was proposed. The application of the proposed algorithm will allow, in some cases, to forego an emergency surgery and obtain a comparable clinical result with less risk for the patient.
- 14 April 2026
- Published by "MedINK" Publishing House in Russian journal of neurosurgery
- Vol. 28 (1)
Pituitary apoplexy – an urgent operation or a wait-and-see strategy?
Background. Pituitary tumors are a common pathology in neuro-oncology. They constitute 10 % of all intracranial tumors; and for a long time, they may not have any clinical manifestations. In situations where pituitary apoplexy is the first manifestation of the disease, the choice of optimal tactics is particularly relevant. Considering cases of spontaneous tumor resorption after pituitary apoplexy, the standard approach to this pathology as an exceptional urgent one requires revision. Aim. To review the treatment strategy of patients with pituitary apoplexy, identifying factors contributing to both tumor resorption and achievement of a better clinical result. After specification of the indications for surgery, to create an algorithm for treating patients with pituitary apoplexy. Materials and methods. The paper analyzes the results of treatment of 82 patients with pituitary apoplexy. Only 45 patients were operated on. In 37 patients, the need for surgery ceased during preparation. Results. Analysis of treatment results of 82 patients with pituitary apoplexy identified optimal tumor parameters and radiological characteristics for which the probability of spontaneous resorption is the highest: 89.2 % (33 out of 37) cases. The use of dexamethasone as part of therapy has shown to play a key role in achieving optimal results. The analysis of the data allowed us to formulate criteria for which a wait-and-see tactic in pituitary apoplexy can provide a result comparable to the surgical method of treatment and even surpassing it in terms of preservation of pituitary functions. Conclusion. As a result of the study, an algorithm for treatment of patients with pituitary apoplexy was proposed. The application of the proposed algorithm will allow, in some cases, to forego an emergency surgery and obtain a comparable clinical result with less risk for the patient.
- 3 April 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (2) , 77-84
Hypothalamic obesity in adults with craniopharyngiomas: prevalence and risk factors before and after neurosurgical treatment
Hypothalamic obesity (weight gain due to hypothalamic damage) is a common complication of surgical treatment of craniopharyngiomas. Data on the prevalence and clinical features of hypothalamic obesity in adults with craniopharyngiomas are scarce, and reports on prognostic factors are contradictory. Objective. To assess the prevalence and risk factors of hypothalamic obesity before and after neurosurgical treatment of craniopharyngiomas in adults. Material and methods. This prospective study included 99 adults with craniopharyngioma. A comprehensive examination was performed. Damage to hypothalamic-pituitary structures was assessed using preoperative MRI, clinical, laboratory and intraoperative data. Results. Pre- and postoperative hypothalamic obesity was detected in 32 (32%) and 47 (57.3%) patients, respectively. Hypothalamic obesity was significantly more common in pituitary stalk and ventricular craniopharyngiomas compared to endosuprasellar craniopharyngiomas (p<0.05). Fifty-nine (71%) patients experienced significant (≥5%) body weight gain after surgery (median 15% [8.8; 24.0] or 11 kg [7; 17]). Analysis of groups with and without hypothalamic obesity after surgery revealed significant differences in baseline body mass index (30.8 kg/m² [27.0; 35.9] and 22.1 kg/m² [19.4; 25.2], respectively, p<0.001), incidence of mental disorders (36.2% and 14.3%, respectively, p=0.027) and preoperative hypogonadism (93.5% and 71.4%, respectively, p=0.013). In multivariate analysis, independent risk factors of hypothalamic obesity were preoperative body mass index with a cutoff value of 27 kg/m² and third ventricular bottom lesions due to tumor infiltration. No effect of histological type of craniopharyngioma, surgical approach or extent of surgery on the incidence of hypothalamic obesity was found. Conclusion. There was high incidence of hypothalamic obesity due to tumor growth and surgical treatment in adults with craniopharyngioma. Predictors of hypothalamic obesity after surgery for craniopharyngioma were baseline body mass index and damage to third ventricle bottom.
- 3 April 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (2) , 77-84
Hypothalamic obesity in adults with craniopharyngiomas: prevalence and risk factors before and after neurosurgical treatment
Hypothalamic obesity (weight gain due to hypothalamic damage) is a common complication of surgical treatment of craniopharyngiomas. Data on the prevalence and clinical features of hypothalamic obesity in adults with craniopharyngiomas are scarce, and reports on prognostic factors are contradictory. Objective. To assess the prevalence and risk factors of hypothalamic obesity before and after neurosurgical treatment of craniopharyngiomas in adults. Material and methods. This prospective study included 99 adults with craniopharyngioma. A comprehensive examination was performed. Damage to hypothalamic-pituitary structures was assessed using preoperative MRI, clinical, laboratory and intraoperative data. Results. Pre- and postoperative hypothalamic obesity was detected in 32 (32%) and 47 (57.3%) patients, respectively. Hypothalamic obesity was significantly more common in pituitary stalk and ventricular craniopharyngiomas compared to endosuprasellar craniopharyngiomas (p<0.05). Fifty-nine (71%) patients experienced significant (≥5%) body weight gain after surgery (median 15% [8.8; 24.0] or 11 kg [7; 17]). Analysis of groups with and without hypothalamic obesity after surgery revealed significant differences in baseline body mass index (30.8 kg/m² [27.0; 35.9] and 22.1 kg/m² [19.4; 25.2], respectively, p<0.001), incidence of mental disorders (36.2% and 14.3%, respectively, p=0.027) and preoperative hypogonadism (93.5% and 71.4%, respectively, p=0.013). In multivariate analysis, independent risk factors of hypothalamic obesity were preoperative body mass index with a cutoff value of 27 kg/m² and third ventricular bottom lesions due to tumor infiltration. No effect of histological type of craniopharyngioma, surgical approach or extent of surgery on the incidence of hypothalamic obesity was found. Conclusion. There was high incidence of hypothalamic obesity due to tumor growth and surgical treatment in adults with craniopharyngioma. Predictors of hypothalamic obesity after surgery for craniopharyngioma were baseline body mass index and damage to third ventricle bottom.